Status:
COMPLETED
The Efficacy and Cost-Effectiveness of Behavioral Counseling for Exercise in Men and Women Following Acute Myocardial Infarction (AMI) and Percutaneous Coronary Intervention (PCI)
Lead Sponsor:
Ottawa Heart Institute Research Corporation
Collaborating Sponsors:
Heart and Stroke Foundation of Ontario
Conditions:
Coronary Arteriosclerosis
Myocardial Infarction
Eligibility:
All Genders
20-85 years
Phase:
PHASE1
Brief Summary
Purpose: The purpose of this project is to determine how effective the telephone-based counseling program is at helping patients with heart disease become more physically active. Hypotheses to be tes...
Detailed Description
Most existing cardiac rehabilitation programs have little ability to expand participation using traditional delivery models that emphasize supervised, facility-based programs. Furthermore, facility-ba...
Eligibility Criteria
Inclusion
- Cardiac Diagnosis:
- 1\) hospitalized patients ready for discharge following successful PCI procedure
- Including patients receiving PCI following admission for AMI or hospitalized post-AMI patients who have not been revascularized
- No lesions with \>50 % stenosis
- English proficiency in reading, writing and speaking
- Age: 20-85 years
Exclusion
- Those patients who are already taking part in another research trial.
- Patient intends to enroll, or is currently enrolled in structured cardiac rehabilitation
- Unable to participate in the on-site cardiac supervised rehab program, cardiac rehab lite, case-managed home cardiac rehab program, Pembroke cardiac rehab program
- Hospitalization for coronary artery bypass (CABG)
- Chronic obstructive pulmonary disease (COPD)
- Hospitalization for diagnostic procedure not associated with previously documented MI
- Patient coming back to hospital for planned staged PCI within 6 months
- Cardiac transplantation
- Presence of, or hospitalization for defibrillator implant
- Hospitalization for pacemaker implantation
- Unresolved unstable angina and/or hospitalization for angina (without MI or PCI)
- Uncontrolled arrhythmias causing symptoms or hemodynamic compromise
- Neuromuscular, musculoskeletal or rheumatoid disorders that are exacerbated by exercise
- Other uncontrolled metabolic conditions (e.g. diabetes)
- Chronic infectious diseases such as mononucleosis, hepatitis, AIDS
- Acute systemic illness or fever
- Uncontrolled tachycardia (\<120 bpm)
- Uncompensated congestive heart failure (and/or NYHA Class III, or IV)
- 3rd degree atrioventricular (AV) block (without pacemaker)
- Active pericarditis or myocarditis
- Recent embolism
- Suspected or known abdominal aortic aneurysm (AAA) \> 4cm
- Uncontrolled hypertension (systolic blood pressure \[SBP\] \>200; diastolic blood pressure \[DBP\] \>110)
- Pregnancy
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
304 Patients enrolled
Trial Details
Trial ID
NCT00250913
Start Date
August 1 2005
End Date
December 1 2009
Last Update
November 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ottawa Heart Institute
Ottawa, Ontario, Canada, K1Y 4W7